** Piper Sandler upgrades medical device maker Solventum SOLV.N to "overweight" from "neutral", raises PT to $87 from $78
** New PT implies 14.8% upside to stock's last close
** Brokerage says co has shown strong execution, with four quarters of clean beats and slight guidance raises, indicating that management is on right track
** Says co has showed consistent improvement in top-line growth and margins
** SOLV's tariff risk appears meaningfully lessened following recent U.S.-China trade tension de-escalation, Piper Sandler says
**Brokerage adds EPS estimates for SOLV have potential upside, driven by co's restructuring efforts, becoming fully independent from its former parent 3M MMM.N and efforts to remove unprofitable products
** Including session's moves, SOLV stock up 12.7% YTD
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.